View Grant Opportunity
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
National Institutes of Health
PAR-25-099
HHS-NIH11
General Information
$225,000
Est. Program Funding:
Est. Program Funding:
December 4, 2026
Closing Date:
Closing Date:
N/a
Expected No. of Awards
Expected No. of Awards
$225,000
Award Ceiling
Award Ceiling
Opportunity Number:
PAR-25-099
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
| The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA. | |
| Response Date | Dec 04, 2026 12:00:00 AM EST |
| Posting Date | Dec 30, 2024 12:00:00 AM EST |
| Archive Date | Jan 09, 2027 12:00:00 AM EST |
| Award Ceiling | 225,000 |
| Award Floor | N/a |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | State governments, City or township governments, County governments, Independent school districts, Native American tribal organizations (other than Federally recognized tribal governments), Private institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Public housing authorities/Indian housing authorities, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Small businesses, Others (see text field entitled "Additional Information on Eligibility" for clarification), Native American tribal governments (Federally recognized), For profit organizations other than small businesses, Public and State controlled institutions of higher education, Special district governments |
| Additional Info on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-099.html |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.855: Allergy and Infectious Diseases Research
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.